Cargando…
Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going?
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500084/ https://www.ncbi.nlm.nih.gov/pubmed/31037916 http://dx.doi.org/10.22074/ijfs.2019.5736 |
_version_ | 1783415888189325312 |
---|---|
author | Barra, Fabio Laganà, Antonio Simone Casarin, Jvan Ghezzi, Fabio Ferro Desideri, Lorenzo Scala, Carolina Ferrero, Simone |
author_facet | Barra, Fabio Laganà, Antonio Simone Casarin, Jvan Ghezzi, Fabio Ferro Desideri, Lorenzo Scala, Carolina Ferrero, Simone |
author_sort | Barra, Fabio |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6500084 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Royan Institute |
record_format | MEDLINE/PubMed |
spelling | pubmed-65000842019-07-01 Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going? Barra, Fabio Laganà, Antonio Simone Casarin, Jvan Ghezzi, Fabio Ferro Desideri, Lorenzo Scala, Carolina Ferrero, Simone Int J Fertil Steril Editorial Royan Institute 2019 2019-04-27 /pmc/articles/PMC6500084/ /pubmed/31037916 http://dx.doi.org/10.22074/ijfs.2019.5736 Text en The Cell Journal (Yakhteh) is an open access journal which means the articles are freely available online for any individual author to download and use the providing address. The journal is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported License which allows the author(s) to hold the copyright without restrictions that is permitting unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited. http://creativecommons.org/licenses/by/3/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Barra, Fabio Laganà, Antonio Simone Casarin, Jvan Ghezzi, Fabio Ferro Desideri, Lorenzo Scala, Carolina Ferrero, Simone Molecular Targets for Endometriosis Therapy: Where We Are and Where We Are Going? |
title | Molecular Targets for Endometriosis Therapy: Where We Are
and Where We Are Going? |
title_full | Molecular Targets for Endometriosis Therapy: Where We Are
and Where We Are Going? |
title_fullStr | Molecular Targets for Endometriosis Therapy: Where We Are
and Where We Are Going? |
title_full_unstemmed | Molecular Targets for Endometriosis Therapy: Where We Are
and Where We Are Going? |
title_short | Molecular Targets for Endometriosis Therapy: Where We Are
and Where We Are Going? |
title_sort | molecular targets for endometriosis therapy: where we are
and where we are going? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500084/ https://www.ncbi.nlm.nih.gov/pubmed/31037916 http://dx.doi.org/10.22074/ijfs.2019.5736 |
work_keys_str_mv | AT barrafabio moleculartargetsforendometriosistherapywhereweareandwherewearegoing AT laganaantoniosimone moleculartargetsforendometriosistherapywhereweareandwherewearegoing AT casarinjvan moleculartargetsforendometriosistherapywhereweareandwherewearegoing AT ghezzifabio moleculartargetsforendometriosistherapywhereweareandwherewearegoing AT ferrodesiderilorenzo moleculartargetsforendometriosistherapywhereweareandwherewearegoing AT scalacarolina moleculartargetsforendometriosistherapywhereweareandwherewearegoing AT ferrerosimone moleculartargetsforendometriosistherapywhereweareandwherewearegoing |